You are currently on the new version of our website. Access the old version .

236 Results Found

  • Article
  • Open Access

Altered Plasma Endocannabinoids and Oxylipins in Adolescents with Major Depressive Disorders: A Case–Control Study

  • Akash Chakravarty,
  • Abinaya Sreetharan,
  • Ester Osuna,
  • Isabelle Herter-Aeberli,
  • Isabelle Häberling,
  • Jeannine Baumgartner,
  • Gregor E. Berger and
  • Martin Hersberger
Nutrients2026, 18(2), 280;https://doi.org/10.3390/nu18020280 
(registering DOI)

15 January 2026

Background: Pediatric Major Depressive Disorder (pMDD) is one of the leading causes of disability in adolescents. There is currently no single explanation that fully accounts for the cause of the disorder, but various factors, including dysregulation...

  • Article
  • Open Access
1 Citations
3,938 Views
10 Pages

2 December 2023

Dysregulated food craving is a complex weight-related behavior. To identify novel targets for enhancing the efficacy of weight loss interventions, we examined whether food craving varies across the menstrual cycle according to the abdominal obesity t...

  • Article
  • Open Access
3 Citations
1,945 Views
15 Pages

Simultaneous Detection of Serotonin and 17β-Estradiol Using rGO/SPCE Modified with Cu(II) Complex: A Novel Approach for PMDD Diagnosis

  • Claudia Núñez,
  • Ronald Nelson,
  • Gerald Tabilo,
  • Paulina Pefaur,
  • Rodrigo Castillo and
  • Alifhers Mestra

Approximately 4% of women of reproductive age are estimated to suffer from premenstrual dysphoric disorder (PMDD), a condition likely underdiagnosed due to various biases, suggesting that actual prevalence may be higher. Addressing this, a novel elec...

  • Brief Report
  • Open Access
1 Citations
1,756 Views
9 Pages

25 May 2024

Premenstrual Dysphoric Disorder (PMDD) is a psychiatric condition characterized by debilitating affective symptomatology in the luteal phase of the menstrual cycle. Based on the previous reports that PMDD may be related to GABAergic cellular dysfunct...

  • Article
  • Open Access
34 Citations
11,482 Views
11 Pages

Early- and Late-Luteal-Phase Estrogen and Progesterone Levels of Women with Premenstrual Dysphoric Disorder

  • Ju-Yu Yen,
  • Huang-Chi Lin,
  • Pai-Cheng Lin,
  • Tai-Ling Liu,
  • Cheng-Yu Long and
  • Chih-Hung Ko

Objective/introduction: The dynamics of ovarian hormone fluctuations during the luteal phase of the menstruation cycle were previously suggested to contribute to the development of premenstrual dysphoric disorder (PMDD) symptoms, but adequate empiric...

  • Article
  • Open Access
21 Citations
6,602 Views
11 Pages

Aim: Premenstrual dysphoric disorder (PMDD) has predictable, cyclic, psychological, and somatic symptoms, such as sleep problems. They result in functional impairment, are aggravated in the late luteal phase of the menstrual cycle, and are resolved b...

  • Article
  • Open Access
8 Citations
4,868 Views
12 Pages

Objective: Cognitive and somatic symptoms were vital factors in developing personalized treatment of depressive disorder. The study aimed to evaluate the following: (1) the cognitive and somatic symptoms of premenstrual dysphoric disorder (PMDD) in t...

  • Article
  • Open Access
10 Citations
5,011 Views
13 Pages

Allopregnanolone Is Associated with a Stress-Induced Reduction of Heart Rate Variability in Premenstrual Dysphoric Disorder

  • Ajna Hamidovic,
  • John Davis,
  • Fatimata Soumare,
  • Aamina Naveed,
  • Yaseen Ghani,
  • Selma Semiz,
  • Dina Khalil and
  • Margaret Wardle

16 February 2023

Human survival and wellbeing require appropriate responses to stress, including a highly coordinated and efficient nervous system control of the heart rhythm. During stress, a greater disinhibition of the vagal nerve is reflective of poor stress adap...

  • Article
  • Open Access
5 Citations
4,556 Views
8 Pages

Beta-Arrestin1 Levels in Mononuclear Leukocytes Support Depression Scores for Women with Premenstrual Dysphoric Disorder

  • Farzana Alam,
  • Sanket Nayyar,
  • William Richie,
  • Anthony Archibong and
  • Tultul Nayyar

Depression is very common in reproductive women particularly with premenstrual dysphoric disorder (PMDD), which is a severe form of premenstrual syndrome (PMS). Beta-arrestins were previously implicated in the pathophysiology, diagnosis and treatment...

  • Article
  • Open Access
1 Citations
2,988 Views
12 Pages

22 October 2023

Previously, we reported that a reduction in β-Arrestin1 protein levels in peripheral blood mononuclear leukocytes (PBMC) significantly correlated with the severity of depression symptoms in women with premenstrual dysphoric disorder (PMDD). This...

  • Article
  • Open Access
19 Citations
5,513 Views
17 Pages

6 May 2016

In order to meet the requirements of high precision and fast response of permanent magnet direct drive (PMDD) wind turbines, this paper proposes a fuzzy proportional integral (PI) controller associated with a new control strategy for wind turbine con...

  • Article
  • Open Access
10 Citations
5,421 Views
19 Pages

3 October 2016

Wind power generation systems require complex control systems with multiple working conditions and multiple controllers. Under different operating conditions, switching without disturbancebetweenthesub-controllersplaysacriticalroleinensuringthestabil...

  • Article
  • Open Access
11 Citations
3,712 Views
11 Pages

NGFR Gene and Single Nucleotide Polymorphisms, rs2072446 and rs11466162, Playing Roles in Psychiatric Disorders

  • Longyou Zhao,
  • Binyin Hou,
  • Lei Ji,
  • Decheng Ren,
  • Fan Yuan,
  • Liangjie Liu,
  • Yan Bi,
  • Fengping Yang,
  • Shunying Yu and
  • Shaochang Wu
  • + 8 authors

9 October 2022

Psychiatric disorders are a class of complex disorders characterized by brain dysfunction with varying degrees of impairment in cognition, emotion, consciousness and behavior, which has become a serious public health issue. The NGFR gene encodes the...

  • Feature Paper
  • Review
  • Open Access
95 Citations
26,381 Views
14 Pages

Cognition, The Menstrual Cycle, and Premenstrual Disorders: A Review

  • Jessica Le,
  • Natalie Thomas and
  • Caroline Gurvich

Sex hormones, such as estrogens, progesterone, and testosterone, have a significant influence on brain, behavior, and cognitive functioning. The menstrual cycle has been a convenient model to examine how subtle fluctuations of these hormones can rela...

  • Review
  • Open Access
34 Citations
48,600 Views
13 Pages

Reproductive Hormones and Female Mental Wellbeing

  • Karolina Wieczorek,
  • Anna Targonskaya and
  • Katherine Maslowski

7 September 2023

Fluctuating hormone levels during the menstrual cycle and major reproductive cycle stages have been linked to mood changes, mental health conditions, and an increased likelihood of psychotic episodes. This knowledge could potentially be used for the...

  • Article
  • Open Access
22 Citations
7,416 Views
11 Pages

Association between Generalized Anxiety Disorder and Premenstrual Dysphoric Disorder in a Diagnostic Interviewing Study

  • Ju-Yu Yen,
  • Pai-Cheng Lin,
  • Mei-Feng Huang,
  • Wei-Po Chou,
  • Cheng-Yu Long and
  • Chih-Hung Ko

Background: Premenstrual dysphoric disorder (PMDD) demonstrates predictable, cyclic, affective and somatic symptoms that are aggravated in the late luteal phase and are resolved by menstruation. Generalized anxiety disorder (GAD) is characterized by...

  • Article
  • Open Access
1,592 Views
9 Pages

Visuospatial Function in Women with Premenstrual Dysphoric Disorder

  • Ajna Hamidovic,
  • Soojeong Cho,
  • Shahd Smadi and
  • John Davis

29 March 2024

Background/Objectives: Premenstrual dysphoric disorder (PMDD) is an understudied psychiatric condition affecting reproductive-age women who experience negative mood in the luteal phase of the menstrual cycle. Cognitive functions in PMDD are not well...

  • Feature Paper
  • Review
  • Open Access
26 Citations
26,622 Views
12 Pages

Premenstrual Syndrome and Premenstrual Dysphoric Disorder as Centrally Based Disorders

  • Rossella E. Nappi,
  • Laura Cucinella,
  • David Bosoni,
  • Alessandra Righi,
  • Federica Battista,
  • Pietro Molinaro,
  • Giulia Stincardini,
  • Manuela Piccinino,
  • Roberta Rossini and
  • Lara Tiranini

16 March 2022

Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) encompass a variety of symptoms that occur during the luteal phase of the menstrual cycle and impair daily life activities and relationships. Depending on the type and severity of...

  • Article
  • Open Access
54 Citations
8,804 Views
16 Pages

Most women experience some premenstrual symptoms during their reproductive years. Yet, this is an under-researched health issue, particularly in the context of work. This study aimed to: (i) understand the prevalence and severity of premenstrual symp...

  • Article
  • Open Access
2 Citations
1,491 Views
23 Pages

Purinergic System Transcript Changes in the Dorsolateral Prefrontal Cortex in Suicide and Major Depressive Disorder

  • Smita Sahay,
  • Anna E. Lundh,
  • Roshan P. Sirole,
  • Robert E. McCullumsmith and
  • Sinead M. O’Donovan

20 February 2025

Suicide is a major public health priority, and its molecular mechanisms appear to be related to imbalanced purine metabolism in the brain. This exploratory study investigates purinergic gene expression in the postmortem dorsolateral prefrontal cortex...

  • Article
  • Open Access
9 Citations
4,218 Views
14 Pages

22 November 2021

The diagnosis of premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) poses a challenge for clinicians due to the overdiagnosis of retrospective methods and overlapping symptoms with depression. The present study utilized an Item Re...

  • Article
  • Open Access
6 Citations
2,240 Views
9 Pages

Premenopausal Singaporean Women Suffering from Major Depressive Disorder Treated with Selective Serotonin Reuptake Inhibitors Had Similar Bone Mineral Density as Compared with Healthy Controls

  • Roger C. Ho,
  • Anna N. Chua,
  • Syeda Fabeha Husain,
  • Wanqiu Tan,
  • Fengyi Hao,
  • Giang T. Vu,
  • Bach X. Tran,
  • Hien Thu Nguyen,
  • Roger S. McIntyre and
  • Cyrus S. Ho

The association between selective serotonin reuptake inhibitor (SSRI) treatment and lower bone mineral density (BMD) remains controversial, and further research is required. This study aimed to compare the BMD, levels of bone formation and bone metab...

  • Article
  • Open Access
30 Citations
7,001 Views
9 Pages

Menstrual Cycle Disorders in Professional Female Rhythmic Gymnasts

  • Mariola Czajkowska,
  • Ryszard Plinta,
  • Magdalena Rutkowska,
  • Anna Brzęk,
  • Violetta Skrzypulec-Plinta and
  • Agnieszka Drosdzol-Cop

The aim of this research was to compare menstrual cycles, menstrual disorders, and the prevalence of premenstrual syndrome (PMS)and premenstrual dysphoric disorder (PMDD) in professional female gymnasts and their peers who donot practice any sport, a...

  • Article
  • Open Access
788 Views
12 Pages

11 November 2025

Premenstrual dysphoric disorder (PMDD) is a psychological condition that significantly influences female students’ behavior, cognitive ability, and mental health status. It has a critical role in mental health and well-being and in the academic...

  • Article
  • Open Access
2 Citations
3,147 Views
11 Pages

Naturalistic Study of Depression Associated with Parkinson’s Disease in a National Public Neurological Referral Center in Mexico

  • Reinhard Janssen-Aguilar,
  • Patricia Rojas,
  • Elizabeth Ruiz-Sánchez,
  • Mayela Rodriguez-Violante,
  • Yessica M. Alcántara-Flores,
  • Daniel Crail-Meléndez,
  • Amin Cervantes-Arriaga,
  • Óscar Sánchez-Escandón and
  • Ángel A. Ruiz-Chow

28 February 2022

Major depressive disorder (MDD) is a major health problem in Parkinson’s disease (PD) patients. We described the clinical and sociodemographic factors of MDD among patients with PD at a national neurological referral center in Mexico. One hundr...

  • Article
  • Open Access
2 Citations
3,511 Views
9 Pages

19 April 2022

Introduction. Insomnia is an important symptom associated with major depressive disorder (MDD). In addition, it is one of the risk factors for suicide. Studies have shown the relationship be-tween insomnia and suicidal behavior in patients with MDD....

  • Article
  • Open Access
4 Citations
4,860 Views
25 Pages

Micronutrients and Major Depression: A Mendelian Randomisation Study

  • Rebecca E. Carnegie,
  • Jie Zheng,
  • Maria C. Borges,
  • Hannah J. Jones,
  • Kaitlin H. Wade,
  • Hannah M. Sallis,
  • Sarah J. Lewis,
  • David M. Evans,
  • Joana A. Revez and
  • Richard M. Martin
  • + 1 author

29 October 2024

Background: Various vitamins and minerals have been implicated in the aetiology of depression. Objective: To estimate the effects of micronutrient exposures on major depressive disorder (MDD) and recurrent depression (rMDD) using Mendelian randomisat...

  • Article
  • Open Access
13 Citations
5,230 Views
14 Pages

The Tryptophan System in Cocaine-Induced Depression

  • Francina Fonseca,
  • Joan-Ignasi Mestre-Pintó,
  • Àlex Gómez-Gómez,
  • Diana Martinez-Sanvisens,
  • Rocío Rodríguez-Minguela,
  • Esther Papaseit,
  • Clara Pérez-Mañá,
  • Klaus Langohr,
  • Olga Valverde and
  • on behalf of NEURODEP GROUP
  • + 2 authors

19 December 2020

Major depression disorder (MDD) is the most prevalent psychiatric comorbid condition in cocaine use disorder (CUD). The comorbid MDD might be primary-MDD (CUD-primary-MDD) or cocaine-induced MDD (CUD-induced-MDD), and their accurate diagnoses and tre...

  • Article
  • Open Access
360 Views
19 Pages

Cerebral Blood Flow and Blood–Brain Barrier Water Exchange in Major Depressive Disorder: Evidence from Diffusion-Prepared Arterial Spin Labelling MRI

  • Simonas Jesmanas,
  • Eglė Milašauskienė,
  • Julius Burkauskas,
  • Vilmantė Borutaitė,
  • Kristina Škėmienė,
  • Virginija Adomaitienė,
  • Brigita Gradauskienė,
  • Saulius Lukoševičius,
  • Rymantė Gleiznienė and
  • Vesta Steiblienė

25 December 2025

Background: Diffusion-prepared pseudo-continuous arterial spin labelling (DP-pCASL) can quantify the cerebral blood flow (CBF) and the water exchange rate (kw) across the blood–brain barrier (BBB). Little is known about the BBB water exchange i...

  • Article
  • Open Access
15 Citations
3,343 Views
11 Pages

The Plasma Levels of 3-Hydroxybutyrate, Dityrosine, and Other Markers of Oxidative Stress and Energy Metabolism in Major Depressive Disorder

  • Michaela Krivosova,
  • Eduard Gondas,
  • Radovan Murin,
  • Matus Dohal,
  • Igor Ondrejka,
  • Ingrid Tonhajzerova,
  • Peter Hutka,
  • Nikola Ferencova,
  • Zuzana Visnovcova and
  • Juraj Mokry

Major depressive disorder (MDD) is a serious mental disease with a pathophysiology that is not yet fully clarified. An increasing number of studies show an association of MDD with energy metabolism alteration and the presence of oxidative stress. We...

  • Article
  • Open Access
8 Citations
3,509 Views
15 Pages

Intrinsic Organization of Occipital Hubs Predicts Depression: A Resting-State fNIRS Study

  • You Xu,
  • Yajie Wang,
  • Nannan Hu,
  • Lili Yang,
  • Zhenghe Yu,
  • Li Han,
  • Qianqian Xu,
  • Jingjing Zhou,
  • Ji Chen and
  • Yafeng Pan

17 November 2022

Dysfunctional brain networks have been found in patients with major depressive disorder (MDD). In this study, to verify this in a more straightforward way, we investigated the intrinsic organization of brain networks in MDD by leveraging the resting-...

  • Feature Paper
  • Article
  • Open Access
3 Citations
2,408 Views
13 Pages

Longitudinal Association of Universal Screening and Treatment for Major Depressive Disorder with Survival in Cancer Patients

  • Yung-Chieh Yen,
  • Chin-Yu Huang,
  • Hsue-Wei Chan,
  • You-Yu Wang,
  • Te-Chang Changchien,
  • Deng-Wu Wang,
  • Po-Chun Lin,
  • Ting-Ting Chang and
  • Yu-Wen Chiu

26 July 2022

Evidence for clinical screening and intervention for depression in cancer and the effect of this intervention on cancer prognosis is suboptimal. This study substantialized a complete model with universal screening and intervention for major depressiv...

  • Review
  • Open Access
27 Citations
6,298 Views
19 Pages

A Systematic Review of Circulatory microRNAs in Major Depressive Disorder: Potential Biomarkers for Disease Prognosis

  • Madiha Rasheed,
  • Rabia Asghar,
  • Sundas Firdoos,
  • Nadeem Ahmad,
  • Amina Nazir,
  • Kakar Mohib Ullah,
  • Noumin Li,
  • Fengyuan Zhuang,
  • Zixuan Chen and
  • Yulin Deng

24 January 2022

Major depressive disorder (MDD) is a neuropsychiatric disorder, which remains challenging to diagnose and manage due to its complex endophenotype. In this aspect, circulatory microRNAs (cimiRNAs) offer great potential as biomarkers and may provide ne...

  • Article
  • Open Access
3 Citations
1,414 Views
12 Pages

Evaluating Apelin as a Potential Biomarker in Major Depressive Disorder: Its Correlation with Clinical Symptomatology

  • Enkhmurun Chibaatar,
  • Rintarou Fujii,
  • Atsuko Ikenouchi,
  • Naomichi Okamoto,
  • Tomoya Natsuyama,
  • Gaku Hayasaki,
  • Takahiro Shinkai and
  • Reiji Yoshimura

20 December 2024

To date, only a limited number of studies have investigated the potential effects of apelin on mood regulation and emotional behavior. Therefore, this study investigated apelin’s role in major depressive disorder (MDD) by comparing the serum an...

  • Article
  • Open Access
6 Citations
2,943 Views
11 Pages

Cognitive Decline and Its Associated Factors in Patients with Major Depressive Disorder

  • Husni Zaim Ab Latiff,
  • Suthahar Ariaratnam,
  • Norley Shuib and
  • Mohamad Rodi Isa

Background: Major Depressive Disorder (MDD) is a significant and common mental health problem occurring worldwide. Cognitive decline is frequently observed during acute and residual phases of MDD, contributing significantly to functional impairment....

  • Article
  • Open Access
8 Citations
3,338 Views
22 Pages

Background: Major depressive disorder (MDD) plays a crucial role in the occurrence of heart failure (HF). This investigation was undertaken to explore the possible mechanism of MDD’s involvement in HF pathogenesis and identify candidate biomark...

  • Article
  • Open Access
1,214 Views
15 Pages

The Relationship Between Binge Eating Behavior and Psychological Pain in Patients with Major Depressive Disorder

  • Aynur Özbay,
  • Mehmet Emin Demirkol,
  • Lut Tamam,
  • Zeynep Namlı,
  • Mahmut Onur Karaytuğ and
  • Caner Yeşiloğlu

22 June 2025

Major Depressive Disorder (MDD) is a chronic mental disorder characterized by anhedonia, loss of desire, guilt, suicidal thoughts, and appetite changes. It is reported that individuals with MDD resort to binge eating to escape from negative feelings....

  • Article
  • Open Access
14 Citations
5,887 Views
11 Pages

Lipid Biomarkers in Depression: Does Antidepressant Therapy Have an Impact?

  • Fidelis Christin Stuchtey,
  • Andrea Block,
  • Francis Osei and
  • Pia-Maria Wippert

9 February 2022

Studies have revealed mixed results on how antidepressant drugs affect lipid profiles of patients with major depression disorder (MDD). Even less is known about how patients respond to a switch of antidepressant medication with respect to their metab...

  • Feature Paper
  • Article
  • Open Access
14 Citations
5,500 Views
10 Pages

Objective: Additional and comorbid diagnoses are common among suicide victims with major depressive disorder (MDD) and have been shown to increase the suicide risk. The aim of the present study was first, to investigate whether patients with severe d...

  • Article
  • Open Access
6 Citations
2,805 Views
10 Pages

Prognostic Role of Minimal Disseminated Disease and NOTCH1/FBXW7 Mutational Status in Children with Lymphoblastic Lymphoma: The AIEOP Experience

  • Federica Lovisa,
  • Ilaria Gallingani,
  • Elena Varotto,
  • Cristiano Pasin,
  • Elisa Carraro,
  • Barbara Michielotto,
  • Anna Garbin,
  • Carlotta Caterina Damanti,
  • Marco Pizzi and
  • Lara Mussolin
  • + 9 authors

1 September 2021

NOTCH1/FBXW7 (N/F) mutational status at diagnosis is employed for T-cell lymphoblastic lymphoma (T-LBL) patients’ stratification in the international protocol LBL 2018. Our aim was to validate the prognostic role of Minimal Disseminated Disease (MDD)...

  • Article
  • Open Access
14 Citations
3,452 Views
12 Pages

Depression Associated with Reduced Heart Rate Variability Predicts Outcome in Adult Congenital Heart Disease

  • Mechthild Westhoff-Bleck,
  • Lars H. Lemke,
  • Jan-Marc S. Bleck,
  • Anja C. Bleck,
  • Johann Bauersachs and
  • Kai G. Kahl

7 April 2021

In adult congenital heart disease (ACHD), major depressive disorder (MDD) represents a frequent comorbidity. In non-CHD, adverse outcome is predicted by MDD and heart rate variability (HRV), whereas in ACHD their prognostic relevance is unknown. We p...

  • Communication
  • Open Access
3 Citations
2,066 Views
10 Pages

BDNF rs962369 Is Associated with Major Depressive Disorder

  • Aneta Bednářová,
  • Viera Habalová and
  • Ivan Tkáč

This study enrolled 291 patients diagnosed with depression and schizophrenia (F32, F33, and F20 according to ICD-10) and 227 ethnicity-matched control subjects. We analyzed the distribution of BDNF rs6265 and BDNF rs962369 genotypes, finding no signi...

  • Article
  • Open Access
17 Citations
3,146 Views
18 Pages

Implication of lncRNA MSTRG.81401 in Hippocampal Pyroptosis Induced by P2X7 Receptor in Type 2 Diabetic Rats with Neuropathic Pain Combined with Depression

  • Ting Zhan,
  • Shanshan Tang,
  • Junpei Du,
  • Jingshuang Liu,
  • Bodong Yu,
  • Yuxin Yang,
  • Yuting Xie,
  • Yanting Qiu,
  • Guodong Li and
  • Yun Gao

18 January 2024

Major depressive disorder (MDD) is a common complication of diabetes and is often observed alongside diabetic neuropathic pain (DNP) as a comorbidity in diabetic patients. Long non-coding RNA (lncRNA) plays an important role in various pathophysiolog...

  • Article
  • Open Access
1 Citations
1,195 Views
12 Pages

11 February 2025

Background and Objectives: Growing evidence suggested that abnormal lipid metabolism (ALM) was associated with an increased severity of depressive symptoms, but no previous studies have examined the differences in comorbid ALM in major depressive dis...

  • Article
  • Open Access
5 Citations
2,753 Views
15 Pages

28 June 2024

Major depressive disorder (MDD) is a prevalent mental illness globally, yet its etiology remains largely elusive. Recent interest in the scientific community has focused on the correlation between the disruption of iron homeostasis and MDD. Prior stu...

  • Article
  • Open Access
7 Citations
3,124 Views
17 Pages

Background: Accumulations of stressful life events result in the onset of major depressive disorder (MDD). Comprehensive genomic analysis is required to elucidate pathophysiological changes and identify applicable biomarkers. Methods: Transcriptomic...

  • Article
  • Open Access
1,899 Views
8 Pages

Exploring miRNA Biomarkers in Major Depressive Disorder: A Molecular Medicine Perspective

  • Cătălin Prodan-Bărbulescu,
  • Laura Andreea Ghenciu,
  • Edward Şeclăman,
  • Georgeta Cristiana Bujor,
  • Virgil Enătescu,
  • Alexandra-Ioana Danila,
  • Ecaterina Dăescu,
  • Luminioara Maria Rosu,
  • Ionuţ Flaviu Faur and
  • Ciprian Duță
  • + 2 authors

27 September 2024

Major depressive disorder (MDD) is a complex mental health condition with a multifaceted and incompletely elucidated pathophysiology. MicroRNAs (miRNAs) have emerged as potential biomarkers due to their role in gene regulation and the observed dysreg...

  • Article
  • Open Access
6 Citations
16,691 Views
12 Pages

The Efficacy of Omega-3 Fatty Acids as the Monotherapy for Depression: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

  • Suet-Kei Wu,
  • Kai-Jie Yang,
  • Wen-Chun Liu,
  • Ikbal Andrian Malau,
  • Halliru Zailani,
  • Cheng-Ho Chang,
  • Shih-Yi Huang,
  • Jane Pei-Chen Chang,
  • Wei-Che Chiu and
  • Kuan-Pin Su

29 October 2024

Objective: Omega-3 polyunsaturated fatty acids (n-3 PUFAs) have demonstrated protective effects in major depressive disorder (MDD) patients receiving antidepressant treatment. However, there have been a few double-blind randomized controlled trials f...

  • Article
  • Open Access
1 Citations
2,742 Views
15 Pages

Plasma Phospholipid Polyunsaturated Fatty Acid Associations with Neurocognition

  • Jinjie Ling,
  • John G. Keilp,
  • Hanga C. Galfalvy,
  • Vanessa N. Cardino,
  • Alyina Ahmed,
  • Ainsley K. Burke,
  • Jenifer I. Fenton,
  • J. John Mann and
  • M. Elizabeth Sublette

26 October 2023

Neurocognitive deficits are implicated in major depressive disorder (MDD) and suicidal behavior, and cognitive function may be affected by blood levels of polyunsaturated fatty acids (PUFAs). Neuroprotective functions have been described for omega-3...

  • Article
  • Open Access
27 Citations
5,539 Views
13 Pages

Differentiating Medicated Patients Suffering from Major Depressive Disorder from Healthy Controls by Spot Urine Measurement of Monoamines and Steroid Hormones

  • Chandra S. Wijaya,
  • Jovia J. Z. Lee,
  • Syeda F. Husain,
  • Cyrus S. H. Ho,
  • Roger S. McIntyre,
  • Wilson W. Tam and
  • Roger C. M. Ho

Introduction: Major Depressive Disorder (MDD) is a common psychiatric disorder. Currently, there is no objective, cost-effective and non-invasive method to measure biological markers related to the pathogenesis of MDD. Previous studies primarily focu...

of 5